Author/Authors :
Aliasgari Majid نويسنده , Fathi Mohammad نويسنده Department of Mining and Metallurgical Engineering, Amirkabir University of Technology, Tehran, Iran Fathi Mohammad , Massoudi Nilofar نويسنده Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , Dadkhah Farid نويسنده , Hesam Alirezaei Amir نويسنده Department of Nephrology, Shahid Modarres Hospital, Shahid
Beheshti University of Medical Sciences, Tehran, Iran , Ahmad Tara Syd نويسنده Department of Nephrology, Shahid Modarres Hospital, Shahid
Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Heart failure is common in patients with chronic renal disease,
either as a complication of renal failure or from shared risk factors,
or is the major cause of death in patients on dialysis. At present, end
stage renal disease (ESRD) patients who have systolic heart failure are
considered high-risk for surgery; and nephrologists and cardiologists
are reluctant to refer these patients for kidney transplant evaluation.
It is unclear whether such patients should be accepted and waitlisted
for transplantation. seven cases with end stage renal disease (ESRD) and
severe heart failure with ejection fraction (EF) of less than 20% and
newyork class 3 - 4, despite being on optimal treatment, who underwent
renal transplant from nonrelative living donor at Shahid Moddaress
hospital in Tehran, Iran during the July 2013 to December 2015, were
retrospectively collected and analysed. The mean ± SD of patient’s age
was 32.7 ± 16 years, and about 72% of them were female. The left
ventricle ejection fraction increased by 35% on an average after the
renal transplantation. Renal transplantation significantly improved the
LV systolic function and ejection fraction status and subsequently
decreased the need for medical treatment and heart transplantation.
